Intrinsiqs

Is Apyx Medical Corporation overvalued?

Apyx Medical Corporation (APYX) — key valuation metrics and fundamentals.

No verdict
Price
$2.81
Fair value
—
Current P/E
—
Normal P/E
41.3
Market cap
$118.4M
Dividend yield
0.0%
Return on equity
-70.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares APYX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.